IMA Advisory Services’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.29M | Buy |
20,484
+1,278
| +7% | +$102K | 0.13% | 115 |
|
|
2025
Q4 | $1.83M | Sell |
19,206
-349
| -2% | -$34.2K | 0.18% | 96 |
|
|
2025
Q3 | $1.91M | Sell |
19,555
-361
| -2% | -$37.4K | 0.19% | 87 |
|
|
2025
Q2 | $2.14M | Buy |
19,916
+47
| +0.2% | +$4.76K | 0.23% | 76 |
|
|
2025
Q1 | $2M | Sell |
19,869
-5,379
| -21% | -$542K | 0.24% | 74 |
|
|
2024
Q4 | $2.26M | Sell |
25,248
-514
| -2% | -$45.2K | 0.27% | 70 |
|
|
2024
Q3 | $2.16M | Buy |
+25,762
| New | +$2.03M | 0.47% | 67 |
|
|
2023
Q4 | – | Sell |
-32,333
| Closed | -$1.71M | – | 92 |
|
|
2023
Q3 | $1.71M | Sell |
32,333
-524
| -2% | -$27.5K | 0.44% | 67 |
|
|
2023
Q2 | $1.78M | Buy |
32,857
+673
| +2% | +$35.1K | 0.46% | 69 |
|
|
2023
Q1 | $1.61M | Sell |
32,184
-1,089
| -3% | -$51.3K | 0.42% | 69 |
|
|
2022
Q4 | $1.54M | Sell |
33,273
-1,424
| -4% | -$61.7K | 0.41% | 68 |
|
|
2022
Q3 | $1.34M | Sell |
34,697
-3,161
| -8% | -$127K | 0.36% | 82 |
|
|
2022
Q2 | $1.41M | Sell |
37,858
-7,056
| -16% | -$287K | 0.35% | 82 |
|
|
2022
Q1 | $1.99M | Buy |
44,914
+845
| +2% | +$36.6K | 0.46% | 73 |
|
|
2021
Q4 | $1.87M | Sell |
44,069
-1,954
| -4% | -$82.1K | 0.41% | 79 |
|
|
2021
Q3 | $2M | Sell |
46,023
-288
| -0.6% | -$12.7K | 0.47% | 72 |
|
|
2021
Q2 | $1.98M | Buy |
46,311
+12,628
| +37% | +$531K | 0.46% | 73 |
|
|
2021
Q1 | $1.3M | Buy |
33,683
+683
| +2% | +$25.9K | 0.32% | 81 |
|
|
2020
Q4 | $1.19M | Sell |
33,000
-15,990
| -33% | -$576K | 0.33% | 77 |
|
|
2020
Q3 | $1.87M | Buy |
48,990
+1,407
| +3% | +$54.2K | 0.63% | 56 |
|
|
2020
Q2 | $1.67M | Sell |
47,583
-32,208
| -40% | -$1.16M | 0.6% | 61 |
|
|
2020
Q1 | $2.6M | Sell |
79,791
-1,470
| -2% | -$57.4K | 1.15% | 28 |
|
|
2019
Q4 | $3.67M | Sell |
81,261
-3,738
| -4% | -$156K | 1.36% | 21 |
|
|
2019
Q3 | $3.46M | Sell |
84,999
-2,941
| -3% | -$125K | 1.31% | 23 |
|
|
2019
Q2 | $3.78M | Sell |
87,940
-32,169
| -27% | -$1.24M | 1.41% | 17 |
|
|
2019
Q1 | $4.61M | Sell |
120,109
-23
| -0% | -$878 | 1.79% | 10 |
|
|
2018
Q4 | $4.25M | Buy |
120,132
+2,317
| +2% | +$84K | 1.98% | 12 |
|
|
2018
Q3 | $4.54M | Buy |
117,815
+1,330
| +1% | +$46.5K | 1.77% | 13 |
|
|
2018
Q2 | $3.81M | Buy |
116,485
+2,243
| +2% | +$67.7K | 1.59% | 15 |
|
|
2018
Q1 | $3.12M | Buy |
+114,242
| New | +$3.1M | 1.39% | 17 |
|
Other funds holding BSX
VCM
VPM
IMA Advisory Services's BSX Position: Q1 2026 in Review
IMA Advisory Services increased its Boston Scientific (BSX) stake by 6.7% in Q1 2026, buying an estimated $102K and bringing the position to 20,484 shares worth $1.29M. The position accounts for 0.13% of the portfolio, ranked #115.
IMA Advisory Services first reported a position in BSX in Q1 2018 and has held it in 30 quarters since. The position peaked at $4.61M in Q1 2019. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.
- IMA Advisory Services held 20,484 shares of Boston Scientific worth $1.29M as of Q1 2026.
- IMA Advisory Services bought 1,278 Boston Scientific shares in Q1 2026, an estimated $102K.
- Boston Scientific made up 0.13% of IMA Advisory Services's portfolio in Q1 2026, its #115 holding.
- IMA Advisory Services first reported a position in Boston Scientific in Q1 2018 and has held it in 30 quarters since.
- IMA Advisory Services's Boston Scientific position peaked at $4.61M in Q1 2019.
- 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.
Based on IMA Advisory Services's 13F filing for Q1 2026, filed 6 May 2026.